title: Clonidine versus captopril for treatment of postpartum very high blood pressure: study protocol for a randomized controlled trial (CLONCAP).
abstract: BACKGROUND
  The behavior of arterial blood pressure in postpartum of women with hypertension and pregnancy and the best treatment for very high blood pressure in this period still need evidence. The Cochrane systematic review assessing prevention and treatment of postpartum hypertension found only two trials (120 patients) comparing hydralazine with nifedipine and labetalol for the treatment of severe hypertension and did not find enough evidence to know how best to treat women with hypertension after birth. Although studies have demonstrated the effectiveness of treatment with captopril, side effects were reported. Because of these findings, new classes of antihypertensive drugs began to be administered as an alternative therapy. Data on the role of clonidine in this particular group of patients, its effects in the short and long term are still scarce in the literature.
  
  
  OBJECTIVE
  To determine the effectiveness of clonidine, compared to captopril, for the treatment of postpartum very high blood pressure in women with hypertension in pregnancy.
  
  
  METHODS
  The study is a triple blind randomized controlled trial including postpartum women with diagnosis of hypertension in pregnancy presenting very high blood pressure, and exclusion criteria will be presence of heart disease, smoking, use of illicit drugs, any contraindication to the use of captopril or clonidine and inability to receive oral medications.Eligible patients will be invited to participate and those who agree will be included in the study and receive captopril or clonidine according to a random list of numbers. The subjects will receive the study medication every 20 minutes until blood pressure is over 170 mmHg of systolic blood pressure and 110 mmHg diastolic blood pressure. A maximum of six pills a day for very high blood pressure will be administered. In case of persistent high blood pressure levels, other antihypertensive agents will be used.During the study the women will be subject to strict control of blood pressure and urine output. This proposal has already obtained approval of the local Institutional Review Board of the coordinating center (IMIP, Recife, Brazil) and of the National Council for Ethics in Research (CONEP) of the Brazilian Ministry of Health.
  
  
  BACKGROUND
  Clinical Trials Register under the number NCT01761916.
authors.affiliation: Obstetric Intensive Care Unit, Instituto de Medicina Integral Prof, Fernando Figueira, Recife, PE, Brazil.
authors.forename: Carlos
authors.initials: C
authors.lastname: Noronha-Neto
authors.forename: Leila
authors.initials: L
authors.lastname: Katz
authors.forename: Isabela C
authors.initials: IC
authors.lastname: Coutinho
authors.forename: Sabina B
authors.initials: SB
authors.lastname: Maia
authors.forename: Alex Sandro Rolland
authors.initials: AS
authors.lastname: Souza
authors.forename: Melania Maria Ramos
authors.initials: MM
authors.lastname: Amorim
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002216:Captopril / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002985:Clinical Protocols; D003000:Clonidine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D015340:Epidemiologic Research Design; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D049590:Postpartum Period; D011786:Quality Control
chemical_list: D000959:Antihypertensive Agents; D002216:Captopril; D003000:Clonidine
references.citation: Best Pract Res Clin Obstet Gynaecol. 2011 Aug;25(4):549-61
references.pmid: 21536498
references.citation: Zhong Xi Yi Jie He Xue Bao. 2010 Jul;8(7):604-12
references.pmid: 20619135
references.citation: Med Res Rev. 1986 Jan-Mar;6(1):75-97
references.pmid: 3005787
references.citation: Am J Obstet Gynecol. 2000 Jul;183(1):S1-S22
references.pmid: 10920346
references.citation: Semin Nephrol. 2011 Jan;31(1):70-85
references.pmid: 21266266
references.citation: BMJ. 1994 Nov 26;309(6966):1395-400
references.pmid: 7819845
references.citation: Clin Pharm. 1993 Mar;12(3):178-9
references.pmid: 8491075
references.citation: N Engl J Med. 2006 Jun 8;354(23):2443-51
references.pmid: 16760444
references.citation: Ann Intern Med. 2013 Feb 5;158(3):200-7
references.pmid: 23295957
references.citation: J Clin Pharmacol. 1981 Feb-Mar;21(2):110-3
references.pmid: 7014657
references.citation: Am J Obstet Gynecol. 2010 Jul;203(1):38.e1-6
references.pmid: 20417492
references.citation: Am J Obstet Gynecol. 2012 Jun;206(6):470-5
references.pmid: 21963308
references.citation: Am J Obstet Gynecol. 2002 Jun;186(6):1174-7
references.pmid: 12066093
references.citation: Cochrane Database Syst Rev. 2013 Apr 30;(4):CD004351
references.pmid: 23633317
references.citation: Lancet. 2001 May 19;357(9268):1619-20
references.pmid: 11386314
references.citation: Am J Obstet Gynecol. 1978 Jul 15;131(6):591-7
references.pmid: 686045
references.citation: Am J Hypertens. 2008 May;21(5):521-6
references.pmid: 18437143
references.citation: Semin Perinatol. 2009 Jun;33(3):130-7
references.pmid: 19464502
references.citation: Int J Gynaecol Obstet. 2011 May;113(2):91-5
references.pmid: 21349517
references.citation: J Clin Hypertens (Greenwich). 2009 Dec;11(12):726-33
references.pmid: 20021530
references.citation: Am J Obstet Gynecol. 1994 Dec;171(6):1642-51
references.pmid: 7802082
references.citation: BJOG. 2002 Jul;109(7):733-6
references.pmid: 12135206
references.citation: Am J Obstet Gynecol. 1989 May;160(5 Pt 1):1112-6
references.pmid: 2524972
references.citation: BMJ Open. 2011 May 24;1(1):e000101
references.pmid: 22021762
references.citation: Obstet Gynecol. 1987 Apr;69(4):598-600
references.pmid: 3822302